(Date:11/24/2009)...,Iceland,November24/PRNewswire-FirstCall/--deCODE,...valofallofits,"firstday"motionsbytheU.S.Bankruptcy...").deCODElastweekfiledavoluntarypetitionfor,relief...he,BankruptcyCourt. , TheordersissuedbytheBan...businessduringtheChapter11proceedings.Inparticular...
(Date:11/24/2009)...Nov.24/PRNewswire-Asia/--ShanghaiBiolaxyannouncedt...sapprovedthe,investigationalnewdrugapplication(IND...ulinformulationtotreatdiabetes.ThisIND,approvalall...,, Diabetesisadisordercharacteristicofhighblood...esoftenresultinseveremicro-and,macro-vasculardisea...
(Date:11/24/2009)...ficacyendpointhasbeenmetforpatientswithadvanced-st...Y,Nov.24/PRNewswire-FirstCall/-AEternaZentarisInc....armaceuticalcompanyfocusedonendocrinetherapyandonc...2studywithitstargetedcytotoxicpeptideconjugate,AEZ...rrentendometrialcancer.Inapersonalizedhealthcareap...
(Date:11/24/2009)...Nov.24,2009/PRNewswire-FirstCall/--ArenaPharmaceut...mpanyisscheduledtopresentatthePiperJaffray21stAnnu...asternTime(8:30a.m.PacificTime)attheNewYorkPalaceH...iefExecutiveOfficer,isscheduledtoprovideanoverview...coveryprograms. ,, Aliveaudiowebcastofthepresen...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2